Profitable Presbyopia - Scorecard - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Profitable Presbyopia

Presbyopia is no longer a condition we simply accommodate; it has become a platform for a longitudinal relationship that can span decades.

  • By

  • Lisa M. Nijm, MD, JD

  • January 1, 2026

  • 10 min

Share

Clinical Scorecard: Profitable Presbyopia

At a Glance

CategoryDetail
ConditionPresbyopia
Key MechanismsPharmacologic correction, intraocular lens advancements, diagnostic improvements
Target PopulationPatients experiencing presbyopia
Care SettingOphthalmology practices

Key Highlights

  • Approval of pilocarpine 1.25% ophthalmic solution for pharmacologic presbyopia correction
  • Introduction of combination pharmacologic therapy with carbachol and brimonidine
  • Refinement of extended-depth-of-focus lenses and enhanced monofocals
  • Importance of ocular surface optimization before any presbyopia intervention
  • Advancements in diagnostic precision with anterior segment imaging and AI assistance

Guideline-Based Recommendations

Diagnosis

  • Utilize advanced diagnostics such as wavefront analysis and pupillometry

Management

  • Consider pharmacologic options for situational near-vision support
  • Evaluate corneal refractive approaches for patients not ready for lens-based surgery

Monitoring & Follow-up

  • Follow up with patients using topical presbyopia agents to engage in further treatment discussions

Risks

  • Ensure identification and treatment of ocular surface issues to prevent dissatisfaction with interventions

Patient & Prescribing Data

Patients with presbyopia seeking vision correction

Pharmacologic agents provide flexibility and can serve as a bridge to surgical options

Clinical Best Practices

  • Optimize ocular surface health before initiating presbyopia treatment
  • Individualize treatment selection based on patient lifestyle and visual goals
  • Engage patients in ongoing discussions about their vision and treatment options

Related Resources & Content

    Original Source(s)

    Profitable Presbyopia

    • by Lisa M. Nijm, MD, JD

    • January 1, 2026

    Related Content

    Which IOLs Are in Your Inventory Closet?

    The Ophthalmic ASC spoke with 4 ophthalmologists about the criteria they use for choosing monofocal, toric, multifocal, extended depth of focus (EDOF), and/or presbyopia-correcting intraocular lenses (PCIOLs). They also shared unmet needs in current IOL technology, what their ideal IOL would be if they could design one, and more.

    Standardizing AI for Dry Eye

    Expert consensus aims to set professional standards for the use of AI in dry eye diagnosis, monitoring, and personalized treatment

    • June 29, 2026

    • 3 min
    CSO Meeting 2026 Highlights Convergence of Innovation and Clinical Practice

    More than 300 professionals gathered for three days of innovation, education, and collaboration, highlighting the latest advances in ophthalmic technology and clinical practice

    • May 12, 2026

    • 2 min